SS
REGN icon

Simplicity Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Simplicity Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$8.27M Buy
9,418
+857
+10% +$706K 0.23% 76
2023
Q3 		$7.05M Sell
8,561
-3,419
-29% -$2.69M 0.23% 83
2023
Q2 		$8.61M Buy
11,980
+299
+3% +$231K 0.24% 83
2023
Q1 		$9.6M Buy
11,681
+10,687
+1,075% +$8.06M 0.25% 79
2022
Q4 		$717K Sell
994
-10
-1% -$7.38K 0.1% 257
2022
Q3 		$692K Buy
1,004
+559
+126% +$352K 0.1% 249
2022
Q2 		$263K Sell
445
-338
-43% -$220K 0.03% 476
2022
Q1 		$547K Sell
783
-59
-7% -$37.3K 0.07% 293
2021
Q4 		$532K Buy
842
+477
+131% +$293K 0.06% 374
2021
Q3 		$221K Buy
+365
New +$227K 0.03% 532
2021
Q1 		– Sell
-859
Closed -$415K – 864
2020
Q4 		$415K Sell
859
-1,583
-65% -$855K 0.01% 717
2020
Q3 		$1.37M Buy
2,442
+67
+3% +$40.6K 0.03% 419
2020
Q2 		$1.48M Buy
2,375
+272
+13% +$154K 0.03% 364
2020
Q1 		$1.03M Buy
2,103
+1,235
+142% +$509K 0.03% 345
2019
Q4 		$326K Hold
868
– – 0.01% 651
2019
Q3 		$241K Buy
868
+72
+9% +$21.3K 0.01% 636
2019
Q2 		$249K Buy
+796
New +$265K 0.01% 559
2018
Q4 		– Sell
-782
Closed -$316K – 757
2018
Q3 		$316K Sell
782
-69
-8% -$26.3K 0.02% 355
2018
Q2 		$294K Buy
851
+218
+34% +$68.2K 0.02% 368
2018
Q1 		$218K Buy
+633
New +$220K 0.02% 338
2016
Q1 		– Sell
-3,605
Closed -$1.96M – 438
2015
Q4 		$1.96M Buy
+3,605
New +$1.95M 0.23% 118

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplicity Solutions's REGN Position: Q4 2023 in Review

Simplicity Solutions increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q4 2023, buying an estimated $706K and bringing the position to 9,418 shares worth $8.27M. The position accounts for 0.23% of the portfolio, ranked #76.

Simplicity Solutions first reported a position in REGN in Q4 2015 and has held it in 21 quarters since. The position peaked at $9.6M in Q1 2023. 1,272 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

  • Simplicity Solutions held 9,418 shares of Regeneron Pharmaceuticals worth $8.27M as of Q4 2023.
  • Simplicity Solutions bought 857 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $706K.
  • Regeneron Pharmaceuticals made up 0.23% of Simplicity Solutions's portfolio in Q4 2023, its #76 holding.
  • Simplicity Solutions first reported a position in Regeneron Pharmaceuticals in Q4 2015 and has held it in 21 quarters since.
  • Simplicity Solutions's Regeneron Pharmaceuticals position peaked at $9.6M in Q1 2023.
  • 1,272 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.